COPD

At Boehringer Ingelheim, we provide innovative treatments for Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF) and Asthma.

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory illness characterised by:

  • chronic airflow limitation
  • shortness of breath (dyspnoea)
  • coughing
  • wheezing and
  • increased sputum (mucus or phlegm) production

These symptoms can limit a patient's normal daily activities. As COPD progresses, lung function decreases and physical activity becomes limited, disrupting daily life and interfering with everyday tasks.

Early diagnosis and treatment is important to prevent complications, improve quality of life, and help patients remain independent.  In order to successfully control COPD an effective management plan and treatment is needed.

Information for...
患者/ご家族の皆様 医療関係者の皆様 獣医療関係者の皆様 報道関係者の皆様